Story perspectives

Eli Lilly Invests $3.5B, Creating 850 Jobs in PA

1/31/2026

22 4

Summary

Story summary

Eli Lilly and Co. will build a $3.5 billion facility in Fogelsville, Pennsylvania, as part of domestic expansion.
The plant will produce injectable drugs, including retatrutide, still under study.
The investment is the largest in Pennsylvania's life sciences sector and will create 850 permanent jobs and 2,000 construction roles.
Lilly's obesity and diabetes drugs, including Zepbound and Mounjaro, drove profit to $5.58 billion and revenue to $17.6 billion, up 50%.

1 of 1

Story summary

Eli Lilly and Co. will build a $3.5 billion facility in Fogelsville, Pennsylvania, as part of domestic expansion.
The plant will produce injectable drugs, including retatrutide, still under study.
The investment is the largest in Pennsylvania's life sciences sector and will create 850 permanent jobs and 2,000 construction roles.
Lilly's obesity and diabetes drugs, including Zepbound and Mounjaro, drove profit to $5.58 billion and revenue to $17.6 billion, up 50%.